NASDAQ:EDIT (Editas Medicine, Inc.)

About EDIT

Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.
  • Editas Medicine, Inc. (NASDAQ: EDIT) Latest News

    No posts found.